| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director +1 more
20 companies
Perceptive Advisors LLC is a 10% Owner at FOLD with holdings across 20 companies. Recent SEC Form 4 filings include 6 buys and 18 sells.
Estimated insider holdings value: $1182.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 45,875 | $3.98 | $182,515.31 | -8.6% | -64.1% | - | |
| Nov 10, 2025 | LYRA Lyra Therapeutics, Inc. | 10% Owner | Sell | 70,390 | $4.89 | $344,219.10 | -10.3% | -65.5% | - | |
| Aug 1, 2025 | OBIO Orchestra Biomed Holdings, Inc. | 10% Owner | Buy | 700,000 | $2.75 | $1,925,000.00 | +15.2% | +64.3% | - | |
| May 1, 2025 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 736,767 | $1.38 | $1,017,919.45 | -10.2% | -0.8% | - | |
| Apr 29, 2025 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Sell | 1,519,952 | $1.81 | $2,744,946.03 | -11.0% | -0.7% | - | |
| Apr 3, 2025 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Sell | 3,400,000 | $1.42 | $4,828,000.00 | -36.7% | +181.7% | +16.9% | |
| Feb 19, 2025 | SLDB Solid Biosciences Inc. | Director, 10% Owner | Buy | 5,000,000 | $4.03 | $20,150,000.00 | +73.2% | -54.4% | -9.1% | |
| Aug 12, 2024 | MGTX Meiragtx Holdings Plc | Director, 10% Owner | Buy | 1,250,000 | $4.00 | $5,000,000.00 | +11.1% | +77.5% | +100.5% | |
| Apr 11, 2024 | ACRV Acrivon Therapeutics, Inc. | 10% Owner | Buy | 2,353,000 | $8.50 | $20,000,500.00 | +78.2% | -22.9% | -82.6% | |
| Apr 5, 2024 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 177,993 | $4.68 | $833,867.15 | +1.0% | -32.4% | -60.0% |